• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯八年监测中病毒性肝炎 A、B 和 C 血清阳性率的趋势。

Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia.

机构信息

Department of Infection Prevention and Control, King Abdulaziz Medical City, PO Box 22490, Riyadh 11426, Saudi Arabia.

出版信息

Int J Infect Dis. 2010 Feb;14(2):e115-20. doi: 10.1016/j.ijid.2009.03.027. Epub 2009 Jun 21.

DOI:10.1016/j.ijid.2009.03.027
PMID:19540786
Abstract

OBJECTIVES

In Saudi Arabia, viral hepatitis ranked the second most common reportable viral disease in 2007, with almost 9000 new cases diagnosed in that year. The objective of this study was to determine the incidence trends of viral hepatitis seropositivity among the population served by the National Guard Health Affairs (NGHA) hospitals in the central, eastern, and western Saudi Arabia regions.

METHODS

The surveillance system at King Abdulaziz Medical City in Riyadh receives weekly reports of laboratory confirmed hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) cases from all NGHA-served regions. In this study the viral hepatitis surveillance data for the period from January 2000 through December 2007 were analyzed.

RESULTS

Between 2000 and 2007, a total of 14 224 seropositive cases of viral hepatitis were reported to the surveillance system. The average annual incidence of seropositivity per 100 000 served population was highest for HBV (104.6), followed by HCV (78.4), and lowest for HAV (13.6). Saudis had higher HBV and HAV incidence, but lower HCV incidence compared to non-Saudis. Over the eight years (2000-2007), the incidence of all three viral hepatitis types showed a 20-30% declining trend. Only HAV incidence followed a clear seasonal cyclic pattern.

CONCLUSIONS

Despite the declining trend over the eight-year period, viral hepatitis, especially that caused by HBV and HCV, remains a major public health problem in Saudi Arabia, and has probably been underestimated in previous reports. There is a need for more comprehensive prevention strategies.

摘要

目的

2007 年,在沙特阿拉伯,病毒性肝炎是报告第二大常见病毒性疾病,当年诊断出近 9000 例新病例。本研究的目的是确定沙特阿拉伯中部、东部和西部地区国民卫队卫生事务(NGHA)医院服务人群中病毒性肝炎血清阳性的发病率趋势。

方法

利雅得阿卜杜勒阿齐兹国王医疗城的监测系统每周从所有 NGHA 服务地区收到实验室确诊甲型肝炎病毒(HAV)、乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)病例的报告。本研究分析了 2000 年至 2007 年期间的病毒性肝炎监测数据。

结果

2000 年至 2007 年期间,监测系统共报告了 14224 例血清阳性病毒性肝炎病例。每 10 万服务人群的血清阳性年平均发病率以 HBV(104.6)最高,其次是 HCV(78.4),HAV 最低(13.6)。与非沙特人相比,沙特人 HBV 和 HAV 的发病率较高,但 HCV 发病率较低。在八年期间(2000-2007 年),所有三种类型的病毒性肝炎发病率均呈 20-30%的下降趋势。只有 HAV 发病率遵循明确的季节性循环模式。

结论

尽管在八年期间呈下降趋势,但病毒性肝炎,尤其是由 HBV 和 HCV 引起的肝炎,仍然是沙特阿拉伯的一个主要公共卫生问题,并且在以前的报告中可能被低估了。需要更全面的预防策略。

相似文献

1
Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia.沙特阿拉伯八年监测中病毒性肝炎 A、B 和 C 血清阳性率的趋势。
Int J Infect Dis. 2010 Feb;14(2):e115-20. doi: 10.1016/j.ijid.2009.03.027. Epub 2009 Jun 21.
2
Profile of viral hepatitis A, B, and C in a Saudi Arabian hospital.沙特一家医院甲型、乙型和丙型病毒性肝炎概况
Med Sci Monit. 2008 Jan;14(1):CR52-56.
3
Viral hepatitis in Bucharest.布加勒斯特的病毒性肝炎
Bull World Health Organ. 1993;71(6):781-6.
4
Surveillance for acute viral hepatitis - United States, 2007.2007年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2009 May 22;58(3):1-27.
5
Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.沙特阿拉伯西部学龄儿童中抗乙肝和抗甲肝抗体的流行情况。
Saudi Med J. 2006 Oct;27(10):1515-22.
6
Surveillance for acute viral hepatitis--United States, 2006.2006年美国急性病毒性肝炎监测
MMWR Surveill Summ. 2008 Mar 21;57(2):1-24.
7
Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.沙特阿拉伯中部地区一家教学医院献血者中乙肝病毒、丙肝病毒、人类免疫缺陷病毒1型、2型及人类嗜T淋巴细胞病毒I/II型感染的流行情况
Saudi Med J. 2004 Jan;25(1):26-33.
8
Seroprevalence of hepatitis A virus markers in Eastern Saudi Arabia.沙特阿拉伯东部甲型肝炎病毒标志物的血清流行率。
Saudi Med J. 2000 Oct;21(10):945-9.
9
Epidemiology of invasive pneumococcal infection in children aged five years and under in Saudi Arabia: a five-year retrospective surveillance study.沙特阿拉伯五岁以下儿童侵袭性肺炎球菌感染的流行病学:一项五年回顾性监测研究。
Int J Infect Dis. 2010 Aug;14(8):e708-12. doi: 10.1016/j.ijid.2010.02.2242.
10
Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.蒙古急性肝炎患者中甲型、乙型、丙型和丁型肝炎病毒感染情况
J Med Virol. 2006 May;78(5):542-50. doi: 10.1002/jmv.20574.

引用本文的文献

1
Upper Gastrointestinal Bleeding: A Retrospective, Single-Center Experience on the Role of Endoscopy and Outcomes.上消化道出血:关于内镜检查作用及结局的单中心回顾性研究
J Clin Med Res. 2025 Jan;17(1):22-34. doi: 10.14740/jocmr6134. Epub 2025 Jan 14.
2
Epidemiological Perspectives: A Four-Year Insight Into Hepatitis C Surveillance in the Kingdom of Saudi Arabia.流行病学视角:沙特阿拉伯王国丙型肝炎监测的四年洞察
Cureus. 2024 Jan 20;16(1):e52646. doi: 10.7759/cureus.52646. eCollection 2024 Jan.
3
Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis.
维持性血液透析患者对乙型肝炎疫苗的体液免疫反应受损。
Saudi J Biol Sci. 2023 Oct;30(10):103788. doi: 10.1016/j.sjbs.2023.103788. Epub 2023 Aug 23.
4
Hepatitis A in the Eastern Mediterranean Region: a comprehensive review.《东地中海区域的甲型肝炎:全面综述》
Hum Vaccin Immunother. 2022 Nov 30;18(5):2073146. doi: 10.1080/21645515.2022.2073146. Epub 2022 May 26.
5
Long-term Immunity Against Hepatitis B Virus After Routine Immunization Among Adults Visiting Primary Care Centers in Riyadh, Saudi Arabia.沙特阿拉伯利雅得初级保健中心成年就诊者常规免疫后对乙型肝炎病毒的长期免疫力
Cureus. 2022 Jan 15;14(1):e21266. doi: 10.7759/cureus.21266. eCollection 2022 Jan.
6
Risk Factors for Hepatitis B Virus Transmission 
in Oman.阿曼乙型肝炎病毒传播的风险因素
Oman Med J. 2021 Jul 31;36(4):e287. doi: 10.5001/omj.2021.99. eCollection 2021 Jul.
7
A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region.沙特阿拉伯和土耳其的儿童甲型肝炎疫苗接种经验回顾:对中东和北非地区甲型肝炎控制和预防的影响。
Hum Vaccin Immunother. 2021 Oct 3;17(10):3710-3728. doi: 10.1080/21645515.2021.1920871. Epub 2021 Jul 2.
8
Evidence of Circulation of Several HAV Genetic Variants and Emergence of Potential Antigenic Variants in an Endemo-Epidemic Country before Vaccine Introduction.在引入疫苗之前,在一个地方性流行国家存在几种 HAV 遗传变异和潜在抗原变异的证据。
Viruses. 2021 Jun 3;13(6):1056. doi: 10.3390/v13061056.
9
Revealing Hepatitis B Virus as a Silent Killer: A Call-to-Action for Saudi Arabia.揭示乙型肝炎病毒为无声杀手:致沙特阿拉伯的行动呼吁。
Cureus. 2021 May 2;13(5):e14811. doi: 10.7759/cureus.14811.
10
Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.突尼斯中西部地区甲型肝炎病毒感染:传播和疫苗接种影响的年龄结构模型。
BMC Infect Dis. 2020 Aug 26;20(1):627. doi: 10.1186/s12879-020-05318-7.